Latest Leverage News

Cleo Diagnostics unveils a pioneering blood test for early ovarian cancer detection, boasting superior accuracy to existing methods and targeting a significant U.S. market opportunity.

Nanoveu Limited has locked in a $500,000 funding guarantee through an options underwriting agreement, underpinning its push to commercialise cutting-edge semiconductor and 3D visualisation technologies.

Talga Group has cleared the last regulatory hurdle for its Nunasvaara South graphite mine in Sweden, paving the way for production of battery anode materials critical to the green transition.

Telix Pharmaceuticals showcased its global theranostic radiopharmaceutical portfolio, highlighting FDA approvals, clinical progress, and a robust commercial expansion plan at its 2025 Investor Day.

DigitalX Limited's treasury reached a record A$75.9 million in May 2025, propelled by increased Solana holdings and enhanced staking yields. The company’s innovative approach balances Bitcoin’s stability with yield-generating digital assets.

Noxopharm’s Sofra™ technology has received promising external validation from BioRay Pharmaceutical, confirming its targeted anti-inflammatory potential and broad applicability in autoimmune disease therapies.

Ventia has landed a major $800 million contract to upgrade 175,000 premises from Fibre to the Node to Fibre to the Premises across Australia, reinforcing its role in the nation’s digital infrastructure.

GenusPlus Group has landed a $130 million contract to upgrade NBN’s Fibre to the Node network across Western Australia, targeting 22,000 properties over the next 3.5 years.

FOS Capital is set to acquire Aldridge Traffic Systems' street lighting assets for $3.1 million, backed by a $3.7 million equity raise to fund the deal and expansion plans.

FOS Capital has secured $3.7 million through a placement to fund its acquisition of Aldridge Traffic Systems, aiming to expand its footprint in the Australian lighting market. The deal includes key assets and intellectual property, positioning FOS for accelerated growth.

ARC Funds Limited plans to acquire the remaining 36.51% stake in The Term Deposit Shop, offering new ARC shares in exchange. This move aims to consolidate ownership and accelerate growth leveraging TTDS’s $530 million Funds under Management.

Invion Limited has addressed ASX queries over the timing and content of its cleansing notice, confirming encouraging early results from its Phase I/II non-melanoma skin cancer trial using Photosoft™ technology.